Buy me a coffee
Home › FDA recalls › MG217 Multi-Symptom Treatment Cream & Skin Protectant
CLASS I · SeriousFDA

Wisconsin Pharmacal Company recalls MG217 Multi-Symptom Treatment Cream & Skin Protectant

📅 Apr 24, 2026 · 📍 Nationwide
Recalling company
Wisconsin Pharmacal Company
Product
MG217 Multi-Symptom Treatment Cream & Skin Protectant (colloidal oatmeal 2%), NET WT 6 oz (170 g), Manufactured by: Pharmacal 1 Pharmacal Way, P.O. Box 198, Jackson, WI 53037.
Reason
Microbial Contamination of Non-Sterile Products: confirmed presence of Staphylococcus Aureus.
Classification
Class I – a reasonable probability that use will cause serious adverse health consequences or death
Recall date
Apr 24, 2026
Reported
May 27, 2026
Distribution
USA Nationwide and Bahamas
Status
Ongoing
Quantity
690 tubes
Lot / codes
Lot #: 1024088, Exp 11/30/2026
Company location
Jackson, WI
Recall type
Voluntary: Firm initiated
Recall number
D-0553-2026
Agency
U.S. Food and Drug Administration (FDA)

View official FDA notice ↗ Search recall number D-0553-2026 in the FDA Enforcement Report. Also see FDA recall press releases.

If you use this product, check the lot, NDC or model number against the official notice and follow its instructions. Do not stop a prescribed medicine or remove a medical device without talking to your doctor or pharmacist. Report problems to FDA MedWatch. FoodRecallNow summarizes public FDA data and is not medical advice.